• Nenhum resultado encontrado

Rev. bras. epidemiol. vol.17 número4

N/A
N/A
Protected

Academic year: 2018

Share "Rev. bras. epidemiol. vol.17 número4"

Copied!
14
0
0

Texto

Loading

Imagem

Table 1. Baseline characteristics of patients evaluated between 1998 and 2010.
Table 3. Analysis of prognostic factors in the total cohort (n = 566).
Figure 1. Survival curves in patients with Non-Small Cell Lung Cancer treated with palliative  chemotherapy between 1998 and 2010 (A) according to gender (B), smoking status (C), Performance  Status (D), staging (E), and weight loss (F) (n = 566).
Table 4. Analysis of prognostic factors in patients treated with palliative chemotherapy (n = 339).
+2

Referências

Documentos relacionados

Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with

Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern

The aim of this study is to investigate whether there is a correlation between anemia, other clinic- pathological factors and survival in patients with advanced NSCLC treated

Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung

(2015) Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with

Other studies, using the monoclonal antibody 8F1[43] have reported that the presence of ERCC1 protein is a prognostic marker of survival in early NSCLC and a predictor of outcome

This study aimed at evaluating the ten-year survival and the prognostic factors for breast cancer in women treated at a referral center for cancer care in southeastern